Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer (PLC)

NCT04145141 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04145141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04145141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer (PLC)
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
July 28, 2021
Completion date
August 6, 2026
Enrollment
132 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, hepatocellular carcinoma, liver cancer